RT @GregVladimer: Just out in @CD_AACR - the final analysis of the EXALT-1 trial - the first prospective interventional study to show how a…
RT @GregVladimer: Just out in @CD_AACR - the final analysis of the EXALT-1 trial - the first prospective interventional study to show how a…
RT @PhilippStaber: Is direct therapy matching possible and of benefit for our patients? YES, please check out our latest paper in @CD_AACR…
RT @giuliosf: What looks like "yet another study" = breakthrough result of a long investment in my laboratory exploring innovative ways to…
RT @DrTonyLetai: Great example of doing the job of precision medicine. Finding the right drugs for the right patients. @TheSFPM
Precision Medicine informed by FUNCTION rather than bioinformatic "omics"
RT @giuliosf: What looks like "yet another study" = breakthrough result of a long investment in my laboratory exploring innovative ways to…
RT @giuliosf: What looks like "yet another study" = breakthrough result of a long investment in my laboratory exploring innovative ways to…
RT @giuliosf: What looks like "yet another study" = breakthrough result of a long investment in my laboratory exploring innovative ways to…
RT @giuliosf: What looks like "yet another study" = breakthrough result of a long investment in my laboratory exploring innovative ways to…
RT @ElizSMcKenna: Now online in @CD_AACR: Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Blood Cancers and…
RT @PhilippStaber: Is direct therapy matching possible and of benefit for our patients? YES, please check out our latest paper in @CD_AACR…
RT @PhilippStaber: Is direct therapy matching possible and of benefit for our patients? YES, please check out our latest paper in @CD_AACR…
RT @TPemovska: Very excited to share our work on bringing Functional Precision Medicine to the clinic for Hematological Cancers patients ou…
RT @MDe_Silva: Congratulations! I’m so excited to continue to see publications like this moving functional precision medicine forward.
RT @GregVladimer: Just out in @CD_AACR - the final analysis of the EXALT-1 trial - the first prospective interventional study to show how a…
RT @GregVladimer: Just out in @CD_AACR - the final analysis of the EXALT-1 trial - the first prospective interventional study to show how a…
RT @GregVladimer: Just out in @CD_AACR - the final analysis of the EXALT-1 trial - the first prospective interventional study to show how a…
RT @GregVladimer: Just out in @CD_AACR - the final analysis of the EXALT-1 trial - the first prospective interventional study to show how a…
RT @giuliosf: What looks like "yet another study" = breakthrough result of a long investment in my laboratory exploring innovative ways to…
RT @giuliosf: What looks like "yet another study" = breakthrough result of a long investment in my laboratory exploring innovative ways to…
RT @GregVladimer: Just out in @CD_AACR - the final analysis of the EXALT-1 trial - the first prospective interventional study to show how a…
RT @giuliosf: What looks like "yet another study" = breakthrough result of a long investment in my laboratory exploring innovative ways to…
Just out in @CD_AACR - the final analysis of the EXALT-1 trial - the first prospective interventional study to show how a functional precision medicine platform can guide treatment selection and improve outcomes in patients with advanced haematological can
RT @giuliosf: What looks like "yet another study" = breakthrough result of a long investment in my laboratory exploring innovative ways to…
Congratulations! I’m so excited to continue to see publications like this moving functional precision medicine forward.
RT @ElizSMcKenna: Now online in @CD_AACR: Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Blood Cancers and…
Functional precision medicine aids in treatment of advanced hematological cancers. Great work by the @PhilippStaber team; @MedUni_Wien
with PDF downloadable #CLL #bloodcancer https://t.co/XRXXiNCsol
RT @PhilippStaber: Honored and thankful to all the fantastic collaborators, and patients who made this possible. Great teamwork to fight ag…
RT @giuliosf: What looks like "yet another study" = breakthrough result of a long investment in my laboratory exploring innovative ways to…
RT @giuliosf: What looks like "yet another study" = breakthrough result of a long investment in my laboratory exploring innovative ways to…
RT @PhilippStaber: Is direct therapy matching possible and of benefit for our patients? YES, please check out our latest paper in @CD_AACR…
RT @PhilippStaber: Honored and thankful to all the fantastic collaborators, and patients who made this possible. Great teamwork to fight ag…
RT @TPemovska: Very excited to share our work on bringing Functional Precision Medicine to the clinic for Hematological Cancers patients ou…
RT @PhilippStaber: Is direct therapy matching possible and of benefit for our patients? YES, please check out our latest paper in @CD_AACR…
RT @ElizSMcKenna: Now online in @CD_AACR: Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Blood Cancers and…
RT @ElizSMcKenna: Now online in @CD_AACR: Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Blood Cancers and…
RT @giuliosf: What looks like "yet another study" = breakthrough result of a long investment in my laboratory exploring innovative ways to…
RT @giuliosf: What looks like "yet another study" = breakthrough result of a long investment in my laboratory exploring innovative ways to…
RT @PhilippStaber: Honored and thankful to all the fantastic collaborators, and patients who made this possible. Great teamwork to fight ag…
RT @ElizSMcKenna: Now online in @CD_AACR: Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Blood Cancers and…
RT @PhilippStaber: Honored and thankful to all the fantastic collaborators, and patients who made this possible. Great teamwork to fight ag…
RT @ElizSMcKenna: Now online in @CD_AACR: Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Blood Cancers and…
RT @DrTonyLetai: Great example of doing the job of precision medicine. Finding the right drugs for the right patients. @TheSFPM
RT @snijderlab: Excited to share the most recent publication of the EXALT-1 trial showing how image-based #SingleCell functional #Precision…
RT @PhilippStaber: Honored and thankful to all the fantastic collaborators, and patients who made this possible. Great teamwork to fight ag…
Now online in @CD_AACR: Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Blood Cancers and Identifies #ExceptionalResponders @CK5haus @TPemovska Ingrid Simonitsch-Klupp @giuliosf @BerendSnijder @PhilippStaber & colleagues
RT @snijderlab: Excited to share the most recent publication of the EXALT-1 trial showing how image-based #SingleCell functional #Precision…
RT @snijderlab: Excited to share the most recent publication of the EXALT-1 trial showing how image-based #SingleCell functional #Precision…
RT @snijderlab: Excited to share the most recent publication of the EXALT-1 trial showing how image-based #SingleCell functional #Precision…
RT @snijderlab: Excited to share the most recent publication of the EXALT-1 trial showing how image-based #SingleCell functional #Precision…
Excited to share the most recent publication of the EXALT-1 trial showing how image-based #SingleCell functional #PrecisionMedicine can improve patient survival in aggressive #BloodCancers. #Pharmacoscopy #CancerDiscovery https://t.co/wxiLg4KZzb
RT @TPemovska: Very excited to share our work on bringing Functional Precision Medicine to the clinic for Hematological Cancers patients ou…
RT @giuliosf: What looks like "yet another study" = breakthrough result of a long investment in my laboratory exploring innovative ways to…
RT @DrTonyLetai: Great example of doing the job of precision medicine. Finding the right drugs for the right patients. @TheSFPM
RT @giuliosf: What looks like "yet another study" = breakthrough result of a long investment in my laboratory exploring innovative ways to…
Honored and thankful to all the fantastic collaborators, and patients who made this possible. Great teamwork to fight aggressive blood cancer! https://t.co/NUfluLntCQ
RT @giuliosf: What looks like "yet another study" = breakthrough result of a long investment in my laboratory exploring innovative ways to…
Is direct therapy matching possible and of benefit for our patients? YES, please check out our latest paper in @CD_AACR https://t.co/NUfluLntCQ
Very excited to share our work on bringing Functional Precision Medicine to the clinic for Hematological Cancers patients out today @CD_AACR . https://t.co/Jq6S82SSxP
RT @giuliosf: What looks like "yet another study" = breakthrough result of a long investment in my laboratory exploring innovative ways to…
RT @giuliosf: What looks like "yet another study" = breakthrough result of a long investment in my laboratory exploring innovative ways to…
Great example of doing the job of precision medicine. Finding the right drugs for the right patients. @TheSFPM
RT @giuliosf: What looks like "yet another study" = breakthrough result of a long investment in my laboratory exploring innovative ways to…
RT @giuliosf: What looks like "yet another study" = breakthrough result of a long investment in my laboratory exploring innovative ways to…
RT @giuliosf: What looks like "yet another study" = breakthrough result of a long investment in my laboratory exploring innovative ways to…
What looks like "yet another study" = breakthrough result of a long investment in my laboratory exploring innovative ways to do "practical" functional precision medicine in my laboratory - we are proud of the team and thankful to all collaborators/patients